CDK9-IN-7
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-126251-5 mg |
| CAS # | 2369981-71-3 |
| Pricing | 5 mg, USD $630.0 |
| Biological Activity | CDK9-IN-7 (compound 21e) is a selective, highly potent, and orally active CDK9/cyclin T inhibitor (IC50=11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD=148 nM; CDK6/cyclinD=145 nM). CDK9-IN-7 shows antitumor activity without obvious toxicity. CDK9-IN-7 induces NSCLC cell apoptosis, arrests the cell cycle in the G2 phase, and suppresses the stemness properties of NSCLC[1]. |
| Purity | 99.81% |
| MWt | 547.71 |
| Formula | C₂₉H₃₇N₇O₂S |